CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Biomarin Pharmaceutical Inc Company Snapshot
Biomarin Pharmaceutical Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Biomarin Pharmaceutical Inc with three other companies in this sector in the United States: Akorn, Inc. (2016 sales of $1.12 billion of which 94% was Prescription Pharmaceuticals), Indivior Plc ($1.06 billion of which 100% was Buprenorphine Based Drugs), and Opko Health Incorporation ($1.22 billion of which 83% was Diagnostics).

Sales Analysis. Biomarin Pharmaceutical Inc reported sales of $1.12 billion for the year ending December of 2016. This represents an increase of 25.5% versus 2015, when the company's sales were $889.90 million. Sales at Biomarin Pharmaceutical Inc have increased during each of the previous five years (and since 2011, sales have increased a total of 153%). Sales of Vimizim saw an increase that was more than double the company's growth rate: sales were up 55.2% in 2016, from $228.15 million to $354.06 million. Biomarin Pharmaceutical Inc also saw significant increases in sales in Kuvan (up 45.4% to $348.01 million) . Not all segments of Biomarin Pharmaceutical Inc experienced an increase in sales in 2016: sales of Aldurazyme fell 4.3% to $93.75 million. Biomarin Pharmaceutical Inc also experienced decreases in sales in Naglazyme (down 2.2% to $296.54 million) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Biomarin Pharmaceutical Inc
  Stock Performance Chart for Biomarin Pharmaceutical Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (11/17/2017): 82.88
(Figures in U.S. Dollars)
1 Week 1.0%   13 Weeks -5.5%  
4 Weeks 2.4%   52 Weeks -6.9%  
 
Biomarin Pharmaceutical Inc Key Data:
  Ticker: BMRN Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 1,116,854,000
(Year Ending Jan 2017).
Employees: 2,293
  Currency: U.S. Dollars Market Cap: 14,545,054,608
  Fiscal Yr Ends: December Shares Outstanding: 175,495,350
  Share Type: Common Closely Held Shares: 655,897
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.